Experimental drug offers hope for genital herpes

accreditation
iStock
An experimental drug could eventually offer a new treatment option for genital herpes, a common and incurable sexually transmitted infection, researchers report.

In a small study, researchers found that the drug – called pritelivir – substantially curbed "viral shedding" in people with genital herpes. That means it decreased the amount of time the virus was active and potentially transmissible to patients' sexual partners.

The findings, reported in the issue of the New England Journal of Medicine, are based on 156 patients followed for just four weeks. Experts cautioned that the study is preliminary and offers a "proof of concept".

First in a new class of drugs

Still, they said, the results are important because pritelivir is the first in a new class of drugs that works differently than existing medications for genital herpes. The hope is that pritelivir will be better at preventing transmission of the virus.

"There was a fairly dramatic decrease in the probability of viral shedding in this study," said Dr. Richard Whitley, an infectious disease expert at the University of Alabama at Birmingham.

There is still a lot of research to be done, said Whitley, who wrote an editorial published with the study. But he said it's good news that drugs that work in new ways are under development.

"We're at the beginning of a new era" in genital herpes treatment, Whitley said.

Read: Genital herpes – the basics

Cause of genital herpes

Genital herpes is caused by the herpes simplex virus – usually the strain known as HSV-2. It's a common disease: An estimated 16 percent of Americans aged 14 to 49 have an HSV-2 infection, according to the US Centres for Disease Control and Prevention.

The infection may cause painful sores around the genitals, rectum or mouth. But, more often, it causes no symptoms or only mild ones, which means most people with HSV are unaware they're infected.

HSV can be dangerous, however. If it's passed from a mother to a newborn, the infection can be fatal. In rare cases, HSV invades the brain and triggers potentially deadly inflammation.

No cure

There is no cure for genital herpes. Once a person is infected, HSV hides out in nerve cells and reactivates periodically – sometimes causing symptoms, sometimes not. Currently, three medications can treat symptoms, and – if taken daily – suppress new symptom outbreaks: acyclovir (brand name Zovirax), famciclovir (Famvir) and valacyclovir (Valtrex).

Even with that daily treatment, there is still viral shedding and the drugs cut HSV transmission by only about half, said Dr. Anna Wald, lead researcher on the new study.

"Clearly, we'd like to do better," said Wald, a professor of allergy and infectious disease at the University of Washington, in Seattle.

Oldest existing drug

Acyclovir, the oldest of the existing drugs, was developed in the 1980s. All three medications had a big impact on managing genital herpes when they came out, said Dr. Lawrence Stanberry, an infectious disease expert at Columbia University Medical Centre/New York-Presbyterian Hospital, in New York City.

Stanberry agreed, however, that the drugs fall short when it comes to preventing HSV transmission. Plus, he said, doctors are seeing some viral resistance to acyclovir in patients with compromised immune systems, such as people with HIV.

The ultimate hope is to develop drugs that eliminate dormant HSV from the nerve cells, said Stanberry, who was not involved in the new study.


Read more:

Genital herpes may never go dormant

Herpes treatment has no effect on HIV

 

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
What are your thoughts on the possibility of having permanent Stage 2 or 3 load shedding?
Please select an option Oops! Something went wrong, please try again later.
Results
I'll take that over constant schedule changes
13% - 1271 votes
Why are we normalising Eskom’s mess?
72% - 7116 votes
I've already found alternative ways of powering my home/business
15% - 1469 votes
Vote
Rand - Dollar
17.10
-0.3%
Rand - Pound
20.96
+0.7%
Rand - Euro
18.67
+0.4%
Rand - Aus dollar
12.11
+0.5%
Rand - Yen
0.13
-0.7%
Platinum
1,024.33
+1.3%
Palladium
1,654.15
-0.9%
Gold
1,918.04
-1.7%
Silver
23.58
-1.6%
Brent Crude
82.84
-3.2%
Top 40
73,629
-0.1%
All Share
79,802
-0.0%
Resource 10
74,686
-0.6%
Industrial 25
102,624
+0.1%
Financial 15
16,551
-0.0%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE